CSS LLC’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-30,000
Closed -$294K 753
2019
Q4
$294K Hold
30,000
0.02% 434
2019
Q3
$207K Hold
30,000
0.01% 441
2019
Q2
$277K Hold
30,000
0.02% 388
2019
Q1
$471K Sell
30,000
-150,000
-83% -$2.65M 0.03% 319
2018
Q4
$2.77M Buy
180,000
+30,000
+20% +$615K 0.19% 112
2018
Q3
$3.23M Hold
150,000
0.14% 110
2018
Q2
$3.65M Sell
150,000
-10,000
-6% -$204K 0.17% 97
2018
Q1
$2.74M Buy
160,000
+50,000
+45% +$976K 0.14% 124
2017
Q4
$2.09M Buy
110,000
+69,500
+172% +$1.05M 0.1% 146
2017
Q3
$713K Buy
+40,500
New +$911K 0.03% 292

Other funds holding TEVA

CSS LLC's TEVA Position: Q2 2026 in Review

CSS LLC held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 27,070 shares worth $917K. The position accounts for 0.04% of the portfolio, ranked #375.

CSS LLC first reported a position in TEVA in Q4 2018 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • CSS LLC held 27,070 shares of Teva Pharmaceutical Industries Limited worth $917K as of Q2 2026.
  • CSS LLC left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.04% of CSS LLC's portfolio in Q2 2026, its #375 holding.
  • CSS LLC first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and has held it in 9 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.